Market Place
Sourcing Support
Lyell Immunopharma Completes Acquisition of ImmPACT Bio
31 Oct 2024 //
GLOBENEWSWIRE
Lyell Immunopharma To Acquire ImmPACT Bio For CAR T-cell
24 Oct 2024 //
GLOBENEWSWIRE
ImmPACT Bio`s IND For MS CAR-T Therapy Cleared By FDA
21 Aug 2024 //
PR NEWSWIRE
ImmPACT Bio To Present MS CAR-T Preclinical Data
21 May 2024 //
PR NEWSWIRE
ImmPACT Bio to Participate in the 2023 Truist Securities BioPharma Symposium
30 Oct 2023 //
PR NEWSWIRE
ImmPACT Bio Granted FDA Fast Track Designation for IMPT-314
15 May 2023 //
PR NEWSWIRE
ImmPACT Bio Appoints Biren Amin, M.B.A. to its Board of Directors
08 Feb 2023 //
PR NEWSWIRE
ImmPACT Bio Announces FDA Clearance of IND for Novel Bispecific CAR
24 Jan 2023 //
PR NEWSWIRE
ImmPACT Bio Names Jonathan Benjamin, M.D., Ph.D. as Chief Medical Officer
13 Sep 2022 //
PRNEWSWIRE
ImmPACT Bio Names Sylvain Roy as Chief Technology Officer
10 May 2022 //
PRNEWSWIRE
Novartis-backed ImmPACT Bio $111M ex-Baxter, Pfizer exec new CEO
19 Jan 2022 //
FIERCEBIOTECH
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.